A study of a GLP-1 medicine in people with lymphedema.

Recruiting now. Registry record last updated June 10, 2025.

Who can join
Adults 18+, have lymphedema, BMI 23+.
What you take
Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts
The full study runs about 2 years.
What you get
Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.
Check my fit →
Phase Phase 1Sponsor Advanced Reconstructive Surgery AllianceDrug GLP-1 Receptor AgonistsClass OtherSites 2 USEnrollment target 110

What this study is for

Primary condition: Lymphedema.

Full scientific study title: Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema.

Who can join

Age18 and upSexAnyBMI23 or higher

Adults 18+, have lymphedema, BMI 23+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Where this trial is enrolling

This trial has 2 sites across 1 state. Contact a site coordinator directly to start screening.

New Jersey2 sites

Timeline

Started enrolling: April 9, 2025. Expected completion: April 9, 2027. Last updated on ClinicalTrials.gov: June 10, 2025.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.